A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 16, 2018

Primary Completion Date

May 24, 2019

Study Completion Date

May 24, 2019

Conditions
Alzheimer DiseaseMild to Moderate Alzheimer Disease
Interventions
DRUG

GRF6019

GRF6019 for IV infusion

Trial Locations (10)

32806

Bioclinica Research, Orlando

33009

MD Clinical, Hallandale

33137

Miami Jewish Health Systems, Miami

33161

Behavioral Clinical Research, North Miami

75115

Serenity Inpatient, DeSoto

84124

PRA Health Sciences, Salt Lake City

90806

CNS Network, Long Beach

91945

Synergy East, Lemon Grove

92103

Pacific Research Network, San Diego

08540

Princeton Medical Institute, Princeton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alkahest, Inc.

INDUSTRY